These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3336426)

  • 1. The efficacy of oral zinc therapy as an alternative to penicillamine for Wilson's disease.
    Cossack ZT
    N Engl J Med; 1988 Feb; 318(5):322-3. PubMed ID: 3336426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
    Kong HL; Yap IL; Kueh YK
    Singapore Med J; 1996 Dec; 37(6):670-2. PubMed ID: 9104075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 6. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral zinc therapy for Wilson's disease.
    Nutr Rev; 1984 May; 42(5):184-6. PubMed ID: 6377131
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral zinc therapy for Wilson's disease.
    Brewer GJ; Hill GM; Prasad AS; Cossack ZT; Rabbani P
    Ann Intern Med; 1983 Sep; 99(3):314-9. PubMed ID: 6614680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC
    Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
    [No Abstract]   [Full Text] [Related]  

  • 12. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
    Alexiou D; Hatzis T; Koutselinis A
    Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc therapy as the initial treatment for Wilson's disease.
    Hoogenraad TU; Van Hattum J
    Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Wilson's disease].
    Hoogenraad TU; van Hattum J
    Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
    Askari FK; Greenson J; Dick RD; Johnson VD; Brewer GJ
    J Lab Clin Med; 2003 Dec; 142(6):385-90. PubMed ID: 14713890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.